You are Trying to View a Free Article
Daily News You Can't Find Anywhere ElseNorth Carolina's Pharma/Biotech Capital Construction Project Activity Remains Strong, an Industrial Info Market Brief
Industry Segment: Market Brief | Word Count: 82 Words
Attachment: Map
North Carolina continues to see a surge of Pharmaceutical/Biotech construction activity. Major firms such as Merck, Eli Lilly, Pfizer and Grifols are either planting or expanding their manufacturing roots in the state. North Carolina's attraction can be attributed to its skilled workforce, state/local incentives, and proximity to other pharma/biotech firms.
Subscribe Now! All Fields Required...
Related Articles
- China Expects More Than $13 Billion in Chemical Processing Projects in Qinz...
- Thailand Delays Revisions to Renewable Energy Plan Due to COVID-19, an Indu...
- Uzbekistan Plans Completion of Chemical Projects Worth $1.24 Billion by End...
- Mato Grosso do Sul Announces First Corn-Based Ethanol Investments, an Indus...
- CNPC, Savannah Proceed with Route Mapping for Niger-Benin Pipeline, an Indu...
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker
All Members Receive the Following Free Resources:
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
